老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BIONDVAX PHARMACEUTICALS SPON ADS EACH REP 400 ORD SHS(POST SPLT)

1.36
0.0000
成交量：- -
成交额：3.03万
市值：496.66万
市盈率：-0.44
高：1.36
开：1.36
低：1.36
收：1.36
数据加载中...
总览公司新闻公告
2023/06/08

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

8-K - Current report
2023/05/04

重要事件披露

8-K - Current report
2023/05/04

重要事件披露

8-K - Current report
2023/04/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/12/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/12/14

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/12/12

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/10/06

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/29

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/03/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/01/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/13

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/06

SEC问询函

CORRESP [Cover] - Correspondence
更多